Administration of Oxygen to Cluster Headache Patients
Not Applicable
Completed
- Conditions
- Cluster Headache Attacks
- Registration Number
- NCT01589588
- Lead Sponsor
- Mads Barløse
- Brief Summary
This study will investigate the possible difference in treatment effect between three different oxygen delivery systems in the acute treatment of cluster headaches.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 57
Inclusion Criteria
- episodic cluster headache
- regular occurance of attacks and cluster for 2 years
- 2-8 attacks / day
- cluster periods of over 14 days
- duration of current cluster period max 14 days
- ability to differentiate between attacks of CH and other forms of headache
Exclusion Criteria
- Changes in prophylactic treatment a week before trial
- pregnancy or breastfeeding women
- serious somatic or psychiatric disease
- COLD
- chronic or primary or secondary headache > 14 days / month other than CH
- alcohol abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Efficacy 15 minutes Pain relief after 15 minutes of treatment
- Secondary Outcome Measures
Name Time Method Mask preference 2 days subject mask preference
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie oxygen's efficacy in alleviating cluster headache attacks via NCT01589588 devices?
How does NCT01589588's oxygen delivery system compare to standard-of-care high-flow oxygen masks for acute cluster headache treatment?
Are there biomarkers associated with differential response to 3 L reservoir vs. demand valve oxygen systems in cluster headache patients?
What adverse events were reported in NCT01589588's oxygen mask interventions and how do they compare to triptan therapy risks?
How do NCT01589588's oxygen delivery devices align with emerging non-pharmacological approaches for cluster headache management?
Trial Locations
- Locations (1)
Danish Headache Center
🇩🇰Glostrup, Denmark
Danish Headache Center🇩🇰Glostrup, Denmark